Compile Data Set for Download or QSAR
Found 89 Enz. Inhib. hit(s) with all data for entry = 50047477
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169546(CHEMBL3805693)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human FP receptor expressed in human Chem1 cells assessed as increase in intracellular calcium level by fluorescence based analys...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169547(CHEMBL3805044)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human FP receptor expressed in human Chem1 cells assessed as increase in intracellular calcium level by fluorescence based analys...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169548(CHEMBL3805176)copy SMILEScopy InChI
Affinity DataEC50:  1.90E+3nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169549(CHEMBL3805169)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169546(CHEMBL3805693)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169547(CHEMBL3805044)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169550(CHEMBL3806130)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM35847((15S)-prostaglandin E2 | (5Z,11alpha,13E,15S)-11,1...)copy SMILEScopy InChI
Affinity DataEC50:  7.5nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50156544(CHEMBL3793209)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169551(CHEMBL3805134)copy SMILEScopy InChI
Affinity DataEC50:  47nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169552(CHEMBL3804978)copy SMILEScopy InChI
Affinity DataEC50:  11nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169548(CHEMBL3805176)copy SMILEScopy InChI
Affinity DataEC50:  2.50E+3nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169549(CHEMBL3805169)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169546(CHEMBL3805693)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169547(CHEMBL3805044)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169550(CHEMBL3806130)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM35847((15S)-prostaglandin E2 | (5Z,11alpha,13E,15S)-11,1...)copy SMILEScopy InChI
Affinity DataEC50:  347nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstacyclin receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50156544(CHEMBL3793209)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human IP receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169552(CHEMBL3804978)copy SMILEScopy InChI
Affinity DataEC50:  33nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169551(CHEMBL3805134)copy SMILEScopy InChI
Affinity DataEC50:  4.60E+3nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50360629(CHEMBL1933725)copy SMILEScopy InChI
Affinity DataEC50:  0.5nMAssay Description:Agonist activity at human EP4 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169553(CHEMBL3805075)copy SMILEScopy InChI
Affinity DataEC50:  7nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169554(CHEMBL3805408)copy SMILEScopy InChI
Affinity DataEC50:  13nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169606(CHEMBL3805122)copy SMILEScopy InChI
Affinity DataEC50:  14nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50156542(CHEMBL3793786)copy SMILEScopy InChI
Affinity DataEC50:  3.90nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169607(CHEMBL3805316)copy SMILEScopy InChI
Affinity DataEC50:  27nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169608(CHEMBL3806076)copy SMILEScopy InChI
Affinity DataEC50:  5.40nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50156543(CHEMBL3793045)copy SMILEScopy InChI
Affinity DataEC50:  0.900nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169609(CHEMBL3805981)copy SMILEScopy InChI
Affinity DataEC50:  0.900nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169610(CHEMBL3805596)copy SMILEScopy InChI
Affinity DataEC50:  6.5nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169611(CHEMBL3805554)copy SMILEScopy InChI
Affinity DataEC50:  3.60nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169612(CHEMBL3806060)copy SMILEScopy InChI
Affinity DataEC50:  23nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169613(CHEMBL3806284)copy SMILEScopy InChI
Affinity DataEC50:  0.5nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169614(CHEMBL3805767)copy SMILEScopy InChI
Affinity DataEC50:  3.30nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50156544(CHEMBL3793209)copy SMILEScopy InChI
Affinity DataEC50:  13nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM35847((15S)-prostaglandin E2 | (5Z,11alpha,13E,15S)-11,1...)copy SMILEScopy InChI
Affinity DataEC50:  1.90nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169550(CHEMBL3806130)copy SMILEScopy InChI
Affinity DataEC50:  1.40nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169547(CHEMBL3805044)copy SMILEScopy InChI
Affinity DataEC50:  10nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169546(CHEMBL3805693)copy SMILEScopy InChI
Affinity DataEC50:  3.80nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169615(CHEMBL3805455)copy SMILEScopy InChI
Affinity DataEC50:  28nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169549(CHEMBL3805169)copy SMILEScopy InChI
Affinity DataEC50:  13nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169548(CHEMBL3805176)copy SMILEScopy InChI
Affinity DataEC50:  3.90nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169552(CHEMBL3804978)copy SMILEScopy InChI
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169551(CHEMBL3805134)copy SMILEScopy InChI
Affinity DataEC50:  8.90E+3nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50360629(CHEMBL1933725)copy SMILEScopy InChI
Affinity DataEC50:  5.60nMAssay Description:Agonist activity at human EP2 receptor expressed in CHO cells assessed as increase in intracellular cAMP level after 30 mins by HTRF methodMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169550(CHEMBL3806130)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human FP receptor expressed in human Chem1 cells assessed as increase in intracellular calcium level by fluorescence based analys...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM35847((15S)-prostaglandin E2 | (5Z,11alpha,13E,15S)-11,1...)copy SMILEScopy InChI
Affinity DataEC50:  250nMAssay Description:Agonist activity at human FP receptor expressed in human Chem1 cells assessed as increase in intracellular calcium level by fluorescence based analys...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50156544(CHEMBL3793209)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human FP receptor expressed in human Chem1 cells assessed as increase in intracellular calcium level by fluorescence based analys...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169612(CHEMBL3806060)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated fo...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Ono Pharmaceutical Co., Ltd.

Curated by ChEMBL
LigandPNGBDBM50169611(CHEMBL3805554)copy SMILEScopy InChI
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at PK2-tagged human EP2 receptor expressed in HEK293 cells assessed as induction of EA-tagged beta-arrestin recruitment incubated fo...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2125VKGPubMed
Displayed 1 to 50 (of 89 total ) | Next | Last >>
Jump to: